Beckman Coulter Life Sciences (Nyon, Switzerland) has announced that it has acquired Blue Ocean Biomedical (Pembroke Pines, Florida, USA), a manufacturer of automated flow cytometry systems and reagents.

The deal provides Beckman Coulter Life Sciences with low complexity analysers that integrate automated sample preparation and address emerging flow cytometry market trends to a broader global market. Blue Ocean Biomedical products complement Beckman's cytometry portfolio with instruments based on a 'sample in, result out' (SIRO) approach.

Scott Atkin, president, Beckman Coulter Life Sciences, commented, “This acquisition provides both immediate opportunity and long-term value. We'll be able to offer customers an extended line of market leading technology while expanding our reach within a key segment for flow cytometry.”

Mike Brochu, CEO and co-founder of Blue Ocean Biomedical, said, “Our team has developed a line of truly unique instrument systems. With its history of leadership and innovation in this field, Beckman Coulter has all the resources and technology needed to build on this platform and future systems for years to come.”